Receptos

Celgene executive blames Receptos for ozanimod filing fail
Fierce Biotech
Wed, 06/13/18 - 10:27 pm
Celgene
Receptos
ozanimod
Ex-Receptos CTO co-founds SD startup Escient, launching with $40M Series A
Endpoints
Wed, 05/9/18 - 09:35 pm
Receptos
Celgene
Marcus Boehm
Escient
G-protein coupled receptors
Is This a Potential $7 Billion Waste for Celgene Corporation?
Motley Fool
Fri, 01/8/16 - 09:39 am
Celgene
Biogen
multiple sclerosis
ozanimod
Receptos
The Best Celgene Corporation Headlines in 2015
Motley Fool
Fri, 01/1/16 - 11:20 am
Celgene
ozanimod
Receptos
What Happened in Biotech in 2015?
Motley Fool
Tue, 12/29/15 - 09:30 am
biotech
Turing Pharmaceuticals
Valeant Pharmaceuticals
Gilead Sciences
drug pricing
M&A
Celgene
Receptos
drug approvals
These Drugs Could Deliver $5 Billion (or More) in Annual Sales
Motley Fool
Sun, 11/1/15 - 11:12 am
Receptos
Celgene
ozanimod
Novo Nordisk
Intra-Cellular Therapies
ITI-007
Celgene nails down $7.2B takeover of Receptos
Fierce Pharma
Fri, 08/28/15 - 12:02 pm
Receptos
Celgene
M&Atttt
4 Reasons To Keep An Eye On Top Biotech Celgene
Investors.com
Sat, 08/22/15 - 08:49 am
Celgene
Revlimid
Juno Therapeutics
Receptos
Celgene's Deal-Making Magic Lifts Receptos 20% in July
Motley Fool
Wed, 08/12/15 - 12:45 pm
Celgene
Receptos
M&A
These 2 Catalysts Helped Push Celgene's Market Value Over $100 Billion in July
Motley Fool
Wed, 08/5/15 - 10:24 am
Celgene
Receptos
M&A
Celgene’s Bid for Receptos Could Be Topped
Barron's
Tue, 08/4/15 - 08:27 am
Celgene
Receptos
M&A
Celgene’s Receptos Deal Almost Came Billions Cheaper in 2013
Bloomberg
Sat, 08/1/15 - 10:35 am
Celgene
Receptos
Ebitda
Is Celgene Brilliant or Downright Crazy?
Motley Fool
Mon, 07/20/15 - 09:05 am
Celgene
M&A
Juno Therapeutics
Receptos
Celgene's $7.2B buyout gets a big thumbs up, but is the deal really done?
Fierce Biotech
Wed, 07/15/15 - 09:52 pm
Celgene
M&A
Receptos
Celgene’s $7.2 Billion Deal Buys Time for Other Bets to Work
Bloomberg
Wed, 07/15/15 - 12:25 pm
Celgene
M&A
Receptos
Celgene chief Bob Hugin isn't done betting on 'binary' biotech deals
Fierce Biotech
Wed, 07/15/15 - 11:18 am
Celgene
Bob Hugin
M&A
Receptos
ozanimod
Celgene to buy Receptos for $7.2 bln; gains promising drug
Yahoo/Reuters
Tue, 07/14/15 - 10:20 pm
Celgene
Receptos
M&A
ozanimod
5 Drugs That Investors May Be Undervaluing
Motley Fool
Mon, 07/13/15 - 11:04 am
Amicus Therapeutics
Galafold
Receptos
ozanimod
GS-5816
Gilead Sciences
ACH-3102
Achillion
Ophthotech
Fovista
Despite insider sale, Receptos stock surges on takeover rumors
BioPharma Dive
Thu, 06/18/15 - 11:14 am
Receptos
M&A
AstraZeneca
Teva Pharmaceutical
Gilead Sciences
MS
multiple sclerosis
Should Biogen Be Afraid of This Upstart?
Investopedia
Mon, 04/13/15 - 10:02 pm
Biogen
Receptos
MS
multiple sclerosis
ozanimod
Tecfidera

Pages